• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲双胍联合百里醌可降低 2 型糖尿病患者的空腹、餐后血糖及糖化血红蛋白。

Thymoquinone with Metformin Decreases Fasting, Post Prandial Glucose, and HbA1c in Type 2 Diabetic Patients.

机构信息

Jina Pharmaceuticals Inc., Libertyville, IL, USA.

Intas Pharmaceuticals Limited, Ahmedabad, Gujarat, India.

出版信息

Drug Res (Stuttg). 2021 Jul;71(6):302-306. doi: 10.1055/a-1388-5415. Epub 2021 Mar 8.

DOI:10.1055/a-1388-5415
PMID:33684953
Abstract

OBJECTIVE

Antihyperglycemic activity of Thymoquinone (TQ) was evaluated in diabetic mouse model and patients.

METHODS

TQ (50 mg/kg) was orally administered daily for 21 days in combination with metformin in diabetic mice and a reduction on blood glucose level was monitored. In human, a 90-day randomized study was carried out in 60 Type 2 Diabetes mellitus patients to evaluate safety and efficacy of TQ administration with metformin in a 3-arm study. Patients in arm 1 (T1) received 1 tablet of metformin SR 1000 mg and 1 tablet of TQ 50 mg once daily. The second arm (T2) patients received 1 tablet of metformin SR 1000 mg and 2 tablets of TQ 50 mg once daily. Patients in arm 3 (R) received 1 tablet of metformin SR 1000 mg only.

RESULTS

The diabetic mice treated with combination of TQ and metformin showed significant decrease in blood sugar compared to those treated with only metformin. In patients who completed the study, the glycated hemoglobin (HbA1c) values in T1, T2 and R decreased after 3 months from 7.2, 7.2 and 7.3 to 6.7, 6.8, and 7.1, respectively. A greater reduction in Fasting Blood Glucose and Post Prandial Blood Glucose was also observed in T1 and T2 arms compared to R.

CONCLUSION

At dose levels of 50 and 100 mg of TQ combined with a daily dose of 1000 mg Metformin demonstrated a reduction in the levels of HbA1c and blood glucose compared to the standard treatment of diabetic patients with metformin alone.

摘要

目的

评估姜酮(TQ)在糖尿病小鼠模型和患者中的降血糖活性。

方法

在糖尿病小鼠中,TQ(50mg/kg)每日口服给药 21 天,并与二甲双胍联合使用,监测血糖水平降低情况。在人体中,对 60 名 2 型糖尿病患者进行了为期 90 天的随机研究,以评估在 3 臂研究中使用二甲双胍联合 TQ 给药的安全性和疗效。第 1 臂(T1)患者每天接受 1 片二甲双胍控释片 1000mg 和 1 片 TQ 50mg;第 2 臂(T2)患者每天接受 1 片二甲双胍控释片 1000mg 和 2 片 TQ 50mg;第 3 臂(R)患者仅接受 1 片二甲双胍控释片 1000mg。

结果

与仅用二甲双胍治疗的小鼠相比,用 TQ 和二甲双胍联合治疗的糖尿病小鼠血糖显著下降。完成研究的患者中,T1、T2 和 R 组的糖化血红蛋白(HbA1c)值在 3 个月后分别从 7.2、7.2 和 7.3 降至 6.7、6.8 和 7.1。与 R 组相比,T1 和 T2 组的空腹血糖和餐后血糖也有更大程度的降低。

结论

与单独使用二甲双胍治疗糖尿病患者的标准治疗相比,TQ 联合 50 和 100mg 剂量的二甲双胍每日剂量可降低 HbA1c 和血糖水平。

相似文献

1
Thymoquinone with Metformin Decreases Fasting, Post Prandial Glucose, and HbA1c in Type 2 Diabetic Patients.二甲双胍联合百里醌可降低 2 型糖尿病患者的空腹、餐后血糖及糖化血红蛋白。
Drug Res (Stuttg). 2021 Jul;71(6):302-306. doi: 10.1055/a-1388-5415. Epub 2021 Mar 8.
2
Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet.每日两次服用瑞格列奈/二甲双胍固定剂量复方片剂可提供与罗格列酮/二甲双胍片剂相当的血糖控制效果。
Diabetes Obes Metab. 2009 Sep;11(9):865-73. doi: 10.1111/j.1463-1326.2009.01062.x. Epub 2009 May 19.
3
Improvement of antihyperglycemic activity of nano-thymoquinone in rat model of type-2 diabetes.提高纳米型二氢青蒿素在 2 型糖尿病大鼠模型中的降血糖活性。
Chem Biol Interact. 2018 Nov 1;295:119-132. doi: 10.1016/j.cbi.2018.02.006. Epub 2018 Feb 5.
4
Effects of two different glibenclamide dose-strengths in the fixed combination with metformin in patients with poorly controlled T2DM: a double blind, prospective, randomised, cross-over clinical trial.两种不同剂量格列本脲与二甲双胍固定复方制剂治疗血糖控制不佳的2型糖尿病患者的疗效:一项双盲、前瞻性、随机、交叉临床试验
Diabetes Nutr Metab. 2004 Dec;17(6):350-7.
5
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.多中心、随机、双盲、平行组评估同时使用格列吡嗪/二甲双胍作为磺脲类药物控制不佳的2型糖尿病患者的二线药物治疗。
Clin Ther. 2003 Mar;25(3):890-903. doi: 10.1016/s0149-2918(03)80112-1.
6
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.在2型糖尿病患者中,使用基础胰岛素类似物的餐时50/50基础胰岛素与餐时胰岛素类似物混合制剂,并联合二甲双胍,以实现糖化血红蛋白(HbA1c)目标值以及餐前和餐后血糖水平:一项多国、24周、随机、开放标签、平行组对照研究。
Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016.
7
Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.每日两次和每日三次服用瑞格列奈/二甲双胍固定剂量复方片剂可提供相似的血糖控制。
Diabetes Obes Metab. 2009 Oct;11(10):947-52. doi: 10.1111/j.1463-1326.2009.01069.x. Epub 2009 Jun 16.
8
Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.二甲双胍联合小剂量格列美脲可显著改善2型糖尿病患者的胰岛素抵抗稳态模型评估(HOMA-IR)及β细胞功能(HOMA-β细胞),且不会导致高胰岛素血症。
Am J Ther. 2007 Mar-Apr;14(2):194-202. doi: 10.1097/01.pap.0000249909.54047.0e.
9
Antidiabetic activity enhancement in streptozotocin + nicotinamide-induced diabetic rats through combinational polymeric nanoformulation.通过组合聚合纳米制剂增强链脲佐菌素+烟酰胺诱导的糖尿病大鼠的抗糖尿病活性。
Int J Nanomedicine. 2019 Jun 12;14:4383-4395. doi: 10.2147/IJN.S205319. eCollection 2019.
10
Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation.2型糖尿病患者的血糖控制从每日两次速释二甲双胍转换为每日一次缓释制剂。
Clin Ther. 2003 Feb;25(2):515-29. doi: 10.1016/s0149-2918(03)80093-0.

引用本文的文献

1
Food-Derived Phytochemicals: Multicultural Approaches to Oxidative Stress and Immune Response.食物来源的植物化学物质:应对氧化应激和免疫反应的多元文化方法
Int J Mol Sci. 2025 Jul 29;26(15):7316. doi: 10.3390/ijms26157316.
2
Effect of Aromatic Herbs and Spices Present in the Mediterranean Diet on the Glycemic Profile in Type 2 Diabetes Subjects: A Systematic Review and Meta-Analysis.地中海饮食中含有的芳香草本植物和香料对 2 型糖尿病患者血糖特征的影响:系统评价和荟萃分析。
Nutrients. 2024 Mar 7;16(6):756. doi: 10.3390/nu16060756.
3
The Use of in Cardiometabolic Diseases.
[此处原文不完整,缺少关键信息,无法准确翻译。若原文为“The Use of [具体事物] in Cardiometabolic Diseases.” ,可译为“[具体事物]在心脏代谢疾病中的应用”]
Biomedicines. 2024 Feb 9;12(2):405. doi: 10.3390/biomedicines12020405.
4
Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer.百里醌:一种用于治疗结直肠癌的有前景的治疗药物。
Curr Issues Mol Biol. 2023 Dec 23;46(1):121-139. doi: 10.3390/cimb46010010.
5
Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer.黑种草醌在结直肠癌中的潜在抗癌特性及机制
Cancer Cell Int. 2023 Dec 12;23(1):320. doi: 10.1186/s12935-023-03174-4.
6
Mechanism of the antidiabetic action of and Thymoquinone: a review.百里醌的抗糖尿病作用机制:综述
Front Nutr. 2023 Sep 25;10:1126272. doi: 10.3389/fnut.2023.1126272. eCollection 2023.
7
L. and Its Active Compound Thymoquinone in the Clinical Management of Diabetes: A Systematic Review.姜黄及其活性化合物姜黄素在糖尿病临床治疗中的应用:系统评价。
Int J Mol Sci. 2022 Oct 11;23(20):12111. doi: 10.3390/ijms232012111.
8
L. Phytochemistry and Pharmacological Activities: A Review (2019-2021).L. 植物化学与药理学活性:综述(2019-2021 年)。
Biomolecules. 2021 Dec 23;12(1):20. doi: 10.3390/biom12010020.
9
Antidiabetic Activity of (Black Seeds) and Its Active Constituent (Thymoquinone): A Review of Human and Experimental Animal Studies.黑种草及其活性成分百里醌的抗糖尿病活性:人体及实验动物研究综述
Chonnam Med J. 2021 Sep;57(3):169-175. doi: 10.4068/cmj.2021.57.3.169. Epub 2021 Sep 24.